Based on the cbdMD Inc stock forecast from 0 analysts, the average analyst target price for cbdMD Inc is not available over the next 12 months. cbdMD Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of cbdMD Inc is Slightly Bearish, which is based on 4 positive signals and 5 negative signals. At the last closing, cbdMD Inc’s stock price was USD 0.35. cbdMD Inc’s stock price has changed by -20.27% over the past week, -24.08% over the past month and -48.88% over the last year.
No recent analyst target price found for cbdMD Inc
No recent average analyst rating found for cbdMD Inc
Company Overview cbdMD Inc
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, and sleep, focus, and calming aids. The company also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name; nootropic mushroom line under the ATRx brand; and hemp derived solutions under the hempMD brand. It distributes its products through its e-commerce website, third-party e-commerce sites, select distributors and marketing partners, wholesalers, and various brick and mortar retailers in the United States. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is headquartered in Charlotte, North Carolina. Read Less
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, a...Read More
Frequently Asked Questions About cbdMD Inc (YCBD) Stock
Stock Target Advisor's fundamental analysis for cbdMD Inc's stock is Slightly Bearish.
Unfortunately we do not have enough data on YCBD's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on YCBD's stock to indicate what its average analyst target is.
YCBD stock's Price/Earning ratio is 0.00.
Our analysis grades YCBD stock's Price / Earning ratio at A+. This means that YCBD stock's Price/Earning ratio is above 0% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NYE exchange.
Based on this YCBD may be undervalued for its sector.
The last closing price of YCBD's stock was USD 0.35.
The most recent market capitalization for YCBD is USD 1.96M.
Unfortunately we do not have enough analyst data on YCBD's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains cbdMD Inc's stock.
As per our most recent records cbdMD Inc has 52 Employees.
cbdMD Inc's registered address is 8845 Red Oak Boulevard, Charlotte, NC, United States, 28217.
You can get more information about it from cbdMD Inc's website at https://www.cbdmd.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Frequently Asked Questions About cbdMD Inc (YCBD) Stock
Stock Target Advisor's fundamental analysis for cbdMD Inc's stock is Slightly Bearish.
Unfortunately we do not have enough data on YCBD's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on YCBD's stock to indicate what its average analyst target is.
YCBD stock's Price/Earning ratio is 0.00.
Our analysis grades YCBD stock's Price / Earning ratio at A+. This means that YCBD stock's Price/Earning ratio is above 0% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NYE exchange.
Based on this YCBD may be undervalued for its sector.
The last closing price of YCBD's stock was USD 0.35.
The most recent market capitalization for YCBD is USD 1.96M.
Unfortunately we do not have enough analyst data on YCBD's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains cbdMD Inc's stock.
As per our most recent records cbdMD Inc has 52 Employees.
cbdMD Inc's registered address is 8845 Red Oak Boulevard, Charlotte, NC, United States, 28217.
You can get more information about it from cbdMD Inc's website at https://www.cbdmd.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for YCBD !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
